These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17173664)

  • 21. Comparison of the validity of the use of the spontaneously hypertensive rat as a model of attention deficit hyperactivity disorder in males and females.
    Bayless DW; Perez MC; Daniel JM
    Behav Brain Res; 2015 Jun; 286():85-92. PubMed ID: 25724583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The usefulness of the spontaneously hypertensive rat to model attention-deficit/hyperactivity disorder (ADHD) may be explained by the differential expression of dopamine-related genes in the brain.
    Li Q; Lu G; Antonio GE; Mak YT; Rudd JA; Fan M; Yew DT
    Neurochem Int; 2007 May; 50(6):848-57. PubMed ID: 17395336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rat models of ADHD.
    Sagvolden T; Johansen EB
    Curr Top Behav Neurosci; 2012; 9():301-15. PubMed ID: 21487952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attention-deficit/hyperactivity disorder (ADHD) behaviour explained by dysfunctioning reinforcement and extinction processes.
    Johansen EB; Aase H; Meyer A; Sagvolden T
    Behav Brain Res; 2002 Mar; 130(1-2):37-45. PubMed ID: 11864716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized, double-blind trial of guanfacine extended release in children with attention-deficit/hyperactivity disorder: morning or evening administration.
    Newcorn JH; Stein MA; Childress AC; Youcha S; White C; Enright G; Rubin J
    J Am Acad Child Adolesc Psychiatry; 2013 Sep; 52(9):921-30. PubMed ID: 23972694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prefrontal cortex Homer expression in an animal model of attention-deficit/hyperactivity disorder.
    Hong Q; Zhang M; Pan XQ; Guo M; Li F; Tong ML; Chen RH; Guo XR; Chi X
    J Neurol Sci; 2009 Dec; 287(1-2):205-11. PubMed ID: 19709672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clozapine decreases exploratory activity and increases anxiety-like behaviour in the Wistar-Kyoto rat but not the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder.
    Mc Fie S; Sterley TL; Howells FM; Russell VA
    Brain Res; 2012 Jul; 1467():91-103. PubMed ID: 22658977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Environmental enrichment improves cognitive deficits in Spontaneously Hypertensive Rats (SHR): relevance for Attention Deficit/Hyperactivity Disorder (ADHD).
    Pamplona FA; Pandolfo P; Savoldi R; Prediger RD; Takahashi RN
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1153-60. PubMed ID: 19549550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lister hooded rats as a novel animal model of attention-deficit/hyperactivity disorder.
    Jogamoto T; Utsunomiya R; Sato A; Kihara N; Choudhury ME; Miyanishi K; Kubo M; Nagai M; Nomoto M; Yano H; Shimizu YI; Fukuda M; Ishii E; Eguchi M; Tanaka J
    Neurochem Int; 2020 Dec; 141():104857. PubMed ID: 33010392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guanfacine treatment improves ADHD phenotypes of impulsivity and hyperactivity in a neurofibromatosis type 1 mouse model.
    Lukkes JL; Drozd HP; Fitz SD; Molosh AI; Clapp DW; Shekhar A
    J Neurodev Disord; 2020 Jan; 12(1):2. PubMed ID: 31941438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type.
    Roessner V; Sagvolden T; Dasbanerjee T; Middleton FA; Faraone SV; Walaas SI; Becker A; Rothenberger A; Bock N
    Neuroscience; 2010 Jun; 167(4):1183-91. PubMed ID: 20211696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The spontaneously hypertensive rat/Izm (SHR/Izm) shows attention deficit/hyperactivity disorder-like behaviors but without impulsive behavior: therapeutic implications of low-dose methylphenidate.
    Kishikawa Y; Kawahara Y; Yamada M; Kaneko F; Kawahara H; Nishi A
    Behav Brain Res; 2014 Nov; 274():235-42. PubMed ID: 25151620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maternal separation increases GABA(A) receptor-mediated modulation of norepinephrine release in the hippocampus of a rat model of ADHD, the spontaneously hypertensive rat.
    Sterley TL; Howells FM; Russell VA
    Brain Res; 2013 Feb; 1497():23-31. PubMed ID: 23276497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rearing in an enriched environment attenuated hyperactivity and inattention in the Spontaneously Hypertensive Rats, an animal model of Attention-Deficit Hyperactivity Disorder.
    Botanas CJ; Lee H; de la Peña JB; Dela Peña IJ; Woo T; Kim HJ; Han DH; Kim BN; Cheong JH
    Physiol Behav; 2016 Mar; 155():30-7. PubMed ID: 26656767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal alpha 2a/d-adrenoceptor subtype function: Wistar as compared to spontaneously hypertensive rats.
    Intengan HD; Smyth DD
    Br J Pharmacol; 1997 Jul; 121(5):861-6. PubMed ID: 9222541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glutamate-stimulated release of norepinephrine in hippocampal slices of animal models of attention-deficit/hyperactivity disorder (spontaneously hypertensive rat) and depression/anxiety-like behaviours (Wistar-Kyoto rat).
    Howells FM; Russell VA
    Brain Res; 2008 Mar; 1200():107-15. PubMed ID: 18295191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Randomized, Placebo-Controlled Trial of Guanfacine Extended Release in Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Wilens TE; Robertson B; Sikirica V; Harper L; Young JL; Bloomfield R; Lyne A; Rynkowski G; Cutler AJ
    J Am Acad Child Adolesc Psychiatry; 2015 Nov; 54(11):916-25.e2. PubMed ID: 26506582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rodent models of attention-deficit/hyperactivity disorder.
    Sagvolden T; Russell VA; Aase H; Johansen EB; Farshbaf M
    Biol Psychiatry; 2005 Jun; 57(11):1239-47. PubMed ID: 15949994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effects of a selective dopamine D1-like receptor agonist on motor activity and c-fos expression in the frontal-striatal circuitry of SHR and Wistar-Kyoto rats.
    Diaz Heijtz R; Castellanos FX
    Behav Brain Funct; 2006 May; 2():18. PubMed ID: 16729883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methylphenidate and venlafaxine attenuate locomotion in spontaneously hypertensive rats, an animal model of attention-deficit/hyperactivity disorder, through α2-adrenoceptor activation.
    Umehara M; Ago Y; Kawanai T; Fujita K; Hiramatsu N; Takuma K; Matsuda T
    Behav Pharmacol; 2013 Aug; 24(4):328-31. PubMed ID: 23751518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.